My Top 2 Recent Tech IPOs to Buy for May 2026

Circle and CoreWeave are highlighted as two of the stronger recent tech IPOs, with Circle's stock up more than 4x from its $31 IPO price and CoreWeave nearly 3x from its $40 IPO price. Circle is expected to benefit from rising USD Coin issuance, with revenue and adjusted EBITDA projected to grow at 26% and 32% CAGRs from 2025 to 2028, while CoreWeave's AI infrastructure business has a $99.4 billion backlog and forecast revenue/EBITDA growth of 97%/101%. The article is constructive on both names, though it flags regulatory risk for stablecoins and leverage risk for CoreWeave.

Analysis

The market is treating both names as pure growth stories, but the more important distinction is cash conversion versus balance-sheet intensity. Circle is effectively a short-duration rates play wrapped in crypto adoption: the equity is levered not to coin count alone, but to the spread between reserve yields and the cost of customer incentives, compliance, and distribution. If policy tightens around passive yield-like behavior, the first-order hit is not only demand; it is a forced mix shift toward lower-margin transaction/API revenue, which would compress operating leverage well before headline stablecoin volumes roll over.

CoreWeave looks stronger structurally, but its advantage is also the source of the fragility. The business model monetizes a supply bottleneck in compute, yet that same scarcity invites rapid capacity build by hyperscalers and GPU vendors, which could compress pricing once customer concentration becomes less tolerable. The backlog growth is impressive, but investors are underweight the asset-liability mismatch: debt-funded GPU purchases lock in depreciation and financing costs now, while contract durability and utilization assumptions can be repriced quickly if AI capex growth slows over the next 6-12 months.

The second-order winner set is likely the infrastructure layer, not the application layer. NVDA benefits if CoreWeave keeps pulling specialized systems forward, but MSFT and META gain negotiating leverage as alternative supply expands; that should cap long-run vendor margins even if near-term demand remains strong. The contrarian read is that both equities may be benefiting from narrative momentum faster than fundamentals can de-risk — in particular, CRCL’s regulatory optionality and CRWV’s concentration risk are being discounted as if they were temporary, when they may be the primary determinants of terminal valuation.

Near term, the catalysts are binary and timing-sensitive: legislation for CRCL over weeks to months, and contract renewal / utilization commentary for CRWV over quarters. A setback in either could trigger sharp multiple compression because both names are priced on forward growth rather than current profitability. The setup favors being selective on entry and using options to define risk rather than paying outright for the full duration of policy and execution uncertainty.

Key Decisions for Investors

• Long CRWV on a pullback rather than strength; prefer staggered entry over 2-4 weeks. Upside remains tied to backlog conversion, but downside is meaningful if AI capex commentary softens or financing costs rise; target a 12-18 month horizon with a 2:1 reward-to-risk profile.
• Avoid chasing CRCL after regulatory headlines; if long, size it as a rates-plus-adoption optionality trade and hedge with a smaller short in high-yield cash alternatives or a basket of crypto-related yield proxies. The key risk is policy-driven margin compression within 1-3 quarters.
• Pair trade: long NVDA / short CRWV for a relative-value expression of infrastructure demand versus execution/leverage risk. This captures continued AI spend while reducing balance-sheet and customer-concentration risk; time horizon 6-12 months.
• If seeking convexity, buy CRCL call spreads instead of stock ahead of legislative milestones. The thesis works only if stablecoin utility expands faster than regulation narrows yield economics; defined-risk structures fit the binary setup.
• Monitor MSFT and META commentary on cloud sourcing and AI infrastructure mix; any evidence of supplier diversification is a warning sign for CRWV’s pricing power and a potential catalyst to reduce exposure.